GeneriCo Announces Collaboration with Zhejiang Hisun to Launch Generic Pharmaceutical Products in the US
Friday, September 09, 2016
GeneriCo, LLC, a global specialty generic pharmaceutical company, has announced the signing of a collaboration with Zhejiang Hisun Pharmaceutical Co, Ltd, and its affiliate Hisun Pharmaceuticals USA, whereby GeneriCo will be the exclusive sales and marketing partner for a portfolio of generic drugs developed and manufactured by Hisun for the US market. As part of the terms, subject to full final agreement, GeneriCo is planning to launch these products during 2016 and 2017.
“This collaboration is a landmark for GeneriCo as it allows us to extend and enhance our commercialization programs ahead of our internally developed generic product launches,” said Tom Brya, President & CEO of GeneriCo.
Shu Zhu, Board Member and Head of Product and Partner Selection at GeneriCo, noted: “This reinforces GeneriCo’s ongoing effort to bring value driven generic products to the U.S. market via our innovative collaboration model, and in alignment with our global view to the industry.”
Source : finance.yahoo.com
